Pharmacoepidemiology of bleeding events after use of r-alteplase or streptokinase in acute myocardial infarction.
McLeod, D C
Pharmacoepidemiology of bleeding events after use of r-alteplase or streptokinase in acute myocardial infarction. [electronic resource] - The Annals of pharmacotherapy - 956-62 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1060-0280
10.1177/106002809302700725 doi
Hemorrhage--chemically induced
Humans
Myocardial Infarction--drug therapy
North Carolina--epidemiology
Retrospective Studies
Streptokinase--adverse effects
Thrombolytic Therapy--adverse effects
Tissue Plasminogen Activator--adverse effects
Pharmacoepidemiology of bleeding events after use of r-alteplase or streptokinase in acute myocardial infarction. [electronic resource] - The Annals of pharmacotherapy - 956-62 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1060-0280
10.1177/106002809302700725 doi
Hemorrhage--chemically induced
Humans
Myocardial Infarction--drug therapy
North Carolina--epidemiology
Retrospective Studies
Streptokinase--adverse effects
Thrombolytic Therapy--adverse effects
Tissue Plasminogen Activator--adverse effects